https://healthpolicy-watch.news/tb-vaccine-550m-boost-for-phase-3-trial/
0
0
6/29/23 at 2:37pm
Organization
Healthpolicy-watch.news
38 words
0
Comments
A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and
You are the first to view
Create an account
or login to join the discussion